> Shares of the UK's Antisoma were on the rise after researchers announced a new batch of positive Phase II data for AS1404 for non-small cell lung cancer. Report
> La Jolla Pharmaceutical today announced positive interim antibody results from its ongoing double-blind, placebo-controlled randomized Phase 3 trial of Riquent. Release
> OncoGenex Technologies has withdrawn its IPO, citing poor market conditions. Release
> The Minneapolis Star-Tribune has an interesting profile of Gel-Del, which is developing an artificial tissue. Article
> Nuvo has updated investors on its talks with the FDA regarding its approvable letter for Pennsaid. Release
> Chutes & Ladders: Stem cell company t2cure has appointed Dr. Manfred Ruediger as CEO. Release
> Researchers for Scripps Research Institute and Eli Lilly have found that a compound called MTIP blocks a brain chemical, triggering a response that can stop excessive drinking, reduce the effects of a hangover and prevent relapses. Report
> Hot nanoprobes used to slow tumor growth in animals. Report
And Finally... With the Dems back in the majority, the debate over drug importation has begun to heat up again. Report